Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
4 Seniors & Aging Demographics Stocks to Watch Right Now
12:10pm, Friday, 21'st Feb 2025
ABBV, AMGN, SYK and DXCM are well-poised to benefit from the evolving new opportunities in Seniors & Aging Demographics within healthcare.
How Dividend Investing Helps Parents Fund College Education Fees
10:18am, Thursday, 20'th Feb 2025
More than half of parents in the United States emphasize paying for their child's college fees as a main concern. Start a UGMA custodial account early, and use the Dividend Growth Investing strategy t
2 Magnificent Dividend Growth Stocks to Load Up On Right Now
05:30am, Thursday, 20'th Feb 2025
Dividend stocks have been the backbone of market returns for over a century, contributing roughly two-thirds of total returns since 1900, according to a report by the Hartford Funds. Companies that co
AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant
12:26pm, Wednesday, 19'th Feb 2025
Since my last analyses on JNJ and ABBV, both have released Q4 earnings. Overall, JNJ showed more pronounced unevenness in its Q4 results, while ABBV's growth story is pretty clear-cut. The goal of thi
My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys
08:10am, Wednesday, 19'th Feb 2025
January saw solid investment activity with $1,500 in net capital added, primarily into Business Development Companies like Owl Rock Capital, Goldman Sachs BDC, and Blackstone Secured Lending Fund. Div
ATLANTA--(BUSINESS WIRE)---- $ABBV #Alzamend--Alzamend Neuro Announces Completion of Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials.
AbbVie Appears Ready To Move Higher
10:55pm, Tuesday, 18'th Feb 2025
AbbVie shares recently rebounded, supported by strong earnings, positive guidance, and a late 2024 dividend increase, indicating the potential for further gains. Despite a $3.5 billion impairment char
Is AbbVie Stock a Buy Now?
04:55am, Saturday, 15'th Feb 2025
AbbVie (ABBV -0.30%) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, the biopharmaceuticals giant delivered 6% sales growth and $2.12 in adjus
The Big 3: ABBV, EA, CEG
11:58am, Friday, 14'th Feb 2025
Today's Big 3 focuses on companies that couldn't be more different, but @ProsperTradingAcademy's Mike Shorr points to one thing they have in common: choppy price action. He talks about the trends he's
AbbVie: An Undervalued Dividend Aristocrat
11:00am, Friday, 14'th Feb 2025
AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets like
AbbVie Just Paid Investors: Here's How Much They Received
08:45am, Friday, 14'th Feb 2025
AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.64, payable on Friday, Feb.
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
07:40am, Friday, 14'th Feb 2025
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025 NORTH CHICAGO, Ill. , Feb. 14, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that its board of directors has
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
07:30am, Friday, 14'th Feb 2025
Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend
AbbVie Declares Quarterly Dividend
11:57am, Thursday, 13'th Feb 2025
NORTH CHICAGO, Ill. , Feb. 13, 2025 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share.
Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
08:30am, Wednesday, 12'th Feb 2025
Allergan Medical Institute (AMI) Training Centers to offer most comprehensive, training programs accelerating providers' consultative and clinical skills Innovative curriculum will empower providers t
